Efficacy and safety of Movicol in combination with or after switching from the existing therapy in patients with chronic constipation(Retrospective observation research)
Not Applicable
- Conditions
- Chronic constipation
- Registration Number
- JPRN-UMIN000037335
- Lead Sponsor
- TSUJINAKA HOSPITAL KASHIWANOHA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 67
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who are suspected constipation due to organic disease 2)Patients with a history of hypersensitivity to any ingredients of Movicol 3)Patients who are confirmed or suspected intestinal obstruction, intestinal perforation, or severe inflammatory bowel disease (ulcerative colitis, Crohn's disease, toxic megacolon, etc.)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method